HERC researcher James Buchanan has written on 'Genomics, the data revolution and health economics' in the BMJ. Click here to read
Admission for applications for 2015-2016 is now closed. Further information on the Nuffield Department of Population Health DPhil (3 year) programme and further information about the combined MSc in Global Health Science/DPhil in Population Health (4 year funded) programme can be found here
Version 3.0 of this database is now available, which is based on updated searches and includes 13 new mapping studies, bringing the total of studies in the database up to 103. The database can be used to estimate utilities for economic evaluation or health technology assessment, identify best practice in mapping studies and to identify or prevent duplicate publication. More information, and access to the database, is available here
Morton, R, Schlackow, I, Mihaylova, B, Staplin, N, Gray, A, and Cass, A (2015). The impact of social disadvantage in moderate-to-severe chronic kidney disease: an equity-focused systematic review. Nephrol Dial Transplant , pii: gfu394. [Epub ahead of print].
Alva, ML, Gray, A, Mihaylova, B, Leal, J, and Holman, RR (2014). The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84). Diabet Med, DOI: 10.1111/dme.12647.
Saw, RPM, Armstrong, BK, Mason, RS, Morton, RL, Shannon, KF, Spillane, AJ, Stretch, JR, and Thompson, JF (2014). Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomised phase II trial (ANZMTG 02.09 Mel-D). BMC Cancer, 14:780.
Watts, CG, Cust, AE, Menzies, SW, Coates, E, Mann, GJ, and Morton, RL (2014). Specialized Surveillance for Individuals at High Risk for Melanoma: A Cost Analysis of a High-Risk Clinic. JAMA Dermatol, EPub Nov 2014. doi:10.1001/jamadermatol.2014.1952.
Tuesday 3 March 2015, 9.00 am
Maarten Ijzerman, Professor of Clinical Epidemiology and HTA; Chair of the Dept. of Health Technology and Services Research, University of Twente, Netherlands 'Is multi-criteria decision analysis useful to guide personalized healthcare decisions: how to deal with missing evidence gaps?'
Monday 23 March 2015 12.00 pm
Béranger Lueza Msc, Dept. Biostatistics and Epidemiology, Gustave Roussy, Université Paris-Sud, Villejuif, France. 'Estimating pooled survival benefit using individual patient-level data meta-analyses in cost-effectiveness analysis of health care technologies: case and simulation study.'
Monday 13 April 2015 12.00 pm
Dr Joel Smith, Health Economist, Centre for Population Health Sciences, University of Edinburgh Medical School
'Bayesian methods (model averaging and belief networks) when mapping from the Modified Rankin Scale to the EQ-5D'
Monday 27 April 2015 12.00 pm
Benjamin Parker, University of Warwick
Introduction to Health Economic Evaluation
23 April 2015, Oxford. COURSE FULL, PLEASE REGISTER FOR WAITING LIST.
24 April 2015, Oxford
15 October 2015, Oxford
16 October 2015, Oxford
- Applied Methods of Cost-Effectiveness Analysis
01-03 JULY 2015, Oxford. COURSE FULL, PLEASE REGISTER FOR WAITING LIST.
Conferences and Workshops co-organised by HERC
Personalised Medicine and Resource Allocation Conference
Organised by the Centre for Personalised Medicine & and the Health Economics Research Centre, University of Oxford
2 March 2015, St Anne's College, Oxford. Registration now closed. More information.
International Health Conference 2015 - a date for your diaries
25-27 June 2015, St Hugh's College, Oxford. More information.